» Articles » PMID: 2210778

Production of a Monoclonal Antibody (K 931) to a Squamous Cell Carcinoma Associated Antigen Identified As the 17-1A Antigen

Overview
Journal Hybridoma
Publisher Mary Ann Liebert
Specialty Cell Biology
Date 1990 Aug 1
PMID 2210778
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

During our efforts to develop monoclonal antibodies (MAbs) to tumor associated surface antigens of squamous cell carcinomas of the head and neck, monoclonal antibody K 931 was produced. The high affinity antibody (Ka 5.0 x 10(10) M-1) showed reactivity with 58 out of 62 squamous cell carcinomas of the head and neck. In contrast normal squamous epithelium as found in epidermis, oral cavity, epiglottis, pharynx, larynx and esophagus did not express the antigen. All other tested epithelial (simple and transitional) tissues did express the antigen, but non-epithelial tissues were negative. Further characterization revealed that the antigen represents the 17-1A antigen. A not earlier reported, enhanced expression of the 17-1A antigen was observed among some primary and all metastatic SCC.

Citing Articles

EPCAM mutation update: Variants associated with congenital tufting enteropathy and Lynch syndrome.

Pathak S, Mueller J, Okamoto K, Das B, Hertecant J, Greenhalgh L Hum Mutat. 2018; 40(2):142-161.

PMID: 30461124 PMC: 6328345. DOI: 10.1002/humu.23688.


Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.

Platt V, Szoka Jr F Mol Pharm. 2008; 5(4):474-86.

PMID: 18547053 PMC: 2772999. DOI: 10.1021/mp800024g.


Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.

Went P, Vasei M, Bubendorf L, Terracciano L, Tornillo L, Riede U Br J Cancer. 2006; 94(1):128-35.

PMID: 16404366 PMC: 2361083. DOI: 10.1038/sj.bjc.6602924.


[Squamous cell carcinoma of the head and neck. Principles and current concepts of immunotherapy].

Hoffmann T, Whiteside T, Bier H HNO. 2005; 53(3):285-97.

PMID: 15759168 DOI: 10.1007/s00106-004-1167-0.


Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck.

Hoffmann T, Bier H, Whiteside T Cancer Immunol Immunother. 2004; 53(12):1055-67.

PMID: 15095020 PMC: 11032895. DOI: 10.1007/s00262-004-0530-z.